[HTML][HTML] Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non …

R Ebina-Shibuya, H Namkoong, N Horita… - Journal of Thoracic …, 2021 - ncbi.nlm.nih.gov
Background Although the US government approved hydroxychloroquine (HCQ) and
chloroquine (CQ) for hospitalized coronavirus disease 19 (COVID-19) patients, some …

[HTML][HTML] Hydroxychloroquine and coronavirus disease 2019: A systematic review of a scientific failure

S Rakedzon, Y Khoury, G Rozenberg… - Rambam Maimonides …, 2020 - ncbi.nlm.nih.gov
Methods We screened for clinical studies describing HCQ administration to treat or prevent
COVID-19 in PubMed. We included randomized controlled trials (RCTs), non-randomized …

Does hydroxychloroquine still have any role in the COVID-19 pandemic?

WHK Schilling, NJ White - Expert Opinion on Pharmacotherapy, 2021 - Taylor & Francis
ABSTRACT Introduction: The 4-aminoquinolines, chloroquine, and hydroxychloroquine
have been used for over 70 years for malaria and rheumatological conditions, respectively …

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter

A Gupta, A Malviya - Postgraduate Medical Journal, 2021 - academic.oup.com
COVID-19 pandemic has brought about a surge in repurposing of drugs, either for the
treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or for …

Therapeutic application of chloroquine in clinical trials for COVID-19

DR Rana, S Dulal - 2020 - pesquisa.bvsalud.org
BackgroundThe novel corona virus disease 2019 (COVID-19) pandemic has been causing
a massive global public health havoc. Use of quinolones for treatment of COVID-19 was a …

Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead

H Singh, P Chauhan, AK Kakkar - European Journal of Pharmacology, 2021 - Elsevier
As mortality and morbidity from novel coronavirus disease (COVID-19) continue to mount
worldwide, the scientific community as well as public health systems are under immense …

Hydroxychloroquine in COVID-19: A systematic review and meta-analysis

J Chacko, G Brar, R Premkumar - Medrxiv, 2020 - medrxiv.org
Background Hydroxychloroquine is being administered among patients with COVID-19
infection in many healthcare systems across the world considering its in vitro effect against …

The efficacy and safety of hydroxychloroquine (HCQ) in treatment of COVID19–a systematic review and meta-analysis

AH Choudhuri, S Duggal, B Ahuja… - Indian Journal of Medical …, 2021 - Elsevier
Introduction The treatment of SARS CoV2 (Severe Acute Respiratory Syndrome corona virus
2) also known as COVID-19 (corona virus disease 2019) continues to remain an enigma …

Hydroxychloroquine in COVID-19: potential mechanism of action against SARS-CoV-2

S Satarker, T Ahuja, M Banerjee, VB E, S Dogra… - Current pharmacology …, 2020 - Springer
Abstract Purpose of Review The rapid spread of virus, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has turned out to be a global emergency. Symptoms of this …

[PDF][PDF] Hydroxychloroquine for COVID-19: what is our current state of knowledge

ZF Udwadia, KN Malu, D Rana… - J Assoc Physicians India, 2020 - researchgate.net
Chloroquine and Hydroxychloroquine are drugs which have been widely used in malaria
and rheumatoid arthritis respectively for over 50 years. There was anecdotal evidence of …